No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial
Storgaard JH, Lokken N, Madsen KL
Published in Journal of Inherited Metabolic Disease
Methodology
Randomised double-blind crossover trial of 1000 mg/day resveratrol for 8 weeks in 9 patients with VLCAD or CPT II deficiency
Key Findings
Resveratrol did not improve fatty acid oxidation or exercise capacity compared with placebo
Conclusions
Mitochondrial-biogenesis agents have not translated into measurable fat oxidation gains in humans
Limitations
Nine patients with rare disorders; short duration
Supplements Studied
No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders
Outcomes Measured
No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.